Health Catalyst (2YP) Price & Analysis

0 Followers

2YP Stock Chart & Stats

€1.08

-€0.15(-2.13%)

At close: Jan 08 4:00 PM EST

€1.08

-€0.15(-2.13%)

Day’s Range― - ―

52-Week Range€0.86 - €3.42

Previous CloseN/A

Volume1.00K

Average Volume (3M)134.00

Market Cap

€147.27M

Enterprise Value€153.95

Total Cash (Recent Filing)€108.82M

Total Debt (Recent Filing)€170.58M

Price to Earnings (P/E)―

Beta0.79

Next Earnings

Aug 12, 2026

EPS Estimate

0.02

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-3.72

Shares Outstanding73,894,020

10 Day Avg. Volume404

30 Day Avg. Volume134

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.68

Price to Sales (P/S)0.54

P/FCF Ratio-704.86

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€1.82

Price Target Upside68.62% Upside

Rating ConsensusHold

Number of Analyst Covering8

EPS Forecast (FY)0.03

Revenue Forecast (FY)€230.94M

Bulls Say, Bears Say

Bulls Say

Balance-sheet De-riskingThe planned Vitalware divestiture and intent to repay the senior term loan materially reduces financial leverage and refinancing risk. Lower debt and a cleaner balance sheet increase flexibility to invest in core AI products, reduce interest expense, and extend runway for execution of strategic initiatives.

Improving Cash GenerationReturn to positive operating and free cash flow demonstrates durable improvement in cash-generation capacity. Positive cash flow funds operations and restructuring, lowers reliance on external financing, and provides a base to sustain product development and customer success investments over the next several quarters.

Higher-margin Tech Mix & AI MomentumA strategic shift toward recurring, higher-margin technology and proprietary AI (Ignite Intelligence) supports sustainable margin expansion and stickier revenue. Product differentiation built on long-form improvement data and measured developer productivity gains can drive durable competitive advantages and operating leverage as adoption scales.

Bears Say

Stagnant/declining RevenueTTM revenue decline signals weakened top-line momentum and challenges in new customer acquisition or expansion. Slower recurring revenue growth limits operating leverage, makes margin recovery harder, and increases pressure on management to convert bookings into sustainable revenue over the medium term.

Structural UnprofitabilityVery wide accounting losses and negative ROE reflect persistent profitability gaps that erode shareholder equity. Even with improved cash flow, structural unprofitability requires sustained margin improvement and execution on cost programs to avoid ongoing dilution and to support long-term value creation.

Migration-driven Churn & Margin PressureCustomer migrations and notified downsells create meaningful recurring-revenue risk and complicate visibility. Coupled with lower services margins, duplicate hosting/data-loading costs, and restructuring timing, churn and migration costs can suppress margins and slow durable ARR expansion absent successful retention and migration execution.

Health Catalyst News

Health Catalyst price target raised to $1.75 from $1 at Wells Fargo

Wells Fargo analyst Stan Berenshteyn raised the firm’s price target on Health Catalyst (HCAT) to $1.75 from $1...

23d ago

HCAT

Health Catalyst: Vitalware Sale Seen as Value-Creating, Enabling Debt Paydown and Strategic Focus; Buy Rating and $2 Price Target Reiterated

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst and keeping the price target...

1M ago

HCAT

Health Catalyst Divests Vitalware to Strengthen Core Focus

Health Catalyst ( ($HCAT) ) just unveiled an update. On June 4, 2026, Health Catalyst agreed to sell...

1M ago

HCAT

Health Catalyst to divest Vitalware to Med-Metrix for $147M in cash

Health Catalyst (HCAT) announced it has signed a definitive agreement to divest Vitalware and the Vitalware business unit,...

1M ago

HCAT

Health Catalyst: Buy Rating Reaffirmed as Strategic Transformation Supports Long-Term Growth Despite Near-Term Estimate Cuts

William Blair analyst Ryan Daniels has maintained their bullish stance on HCAT stock, giving a Buy rating on...

2M ago

HCAT

Health Catalyst Earnings Call Maps Costly Transition

Health Catalyst (($HCAT)) has held its Q1 earnings call. Read on for the main highlights of the call....

2M ago

HCAT

Health Catalyst: Buy Rating Reiterated on Project Nexus Progress, Margin Upside, and Unchanged $2 Price Target

Canaccord Genuity analyst Richard Close maintained a Buy rating on Health Catalyst today and set a price target...

2M ago

HCAT

Health Catalyst price target lowered to $1.75 from $2 at Stephens

Stephens lowered the firm’s price target on Health Catalyst (HCAT) to $1.75 from $2 and keeps an Equal...

2M ago

HCAT

Health Catalyst reports Q1 adjusted EPS 2c, consensus 1c

Reports Q1 revenue $70.76M, consensus $69.19M. “We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding...

2M ago

HCAT

Health Catalyst sees Q2 revenue $68M-$70M, consensus $70.47M

Sees Q2 adjusted EBITDA $9M-$10M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

2M ago

HCAT

Health Catalyst sees FY26 revenue $260M-$265M, consensus $278.88M

Sees FY26 adjusted EBITDA $30M-$33M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

2M ago

HCAT

HCAT Upcoming Earnings Report: What to Expect?

Health Catalyst (HCAT) is scheduled to report 1st quarter earnings on 05/11/2026, after the market closes. Regarding Q1...

2M ago

HCAT

Health Catalyst Adds Steve Nelson to Board of Directors

The latest announcement is out from Health Catalyst ( ($HCAT) ). On April 29, 2026, Health Catalyst’s board...

3M ago

HCAT

Health Catalyst announces 9% global workforce reduction

In a regulatory filing, the company said, “As part of Project Nexus, a strategic initiative designed to fundamentally...

3M ago

HCAT

2YP FAQ

What was Health Catalyst’s price range in the past 12 months?

Health Catalyst lowest stock price was €0.85 and its highest was €3.42 in the past 12 months.

What is Health Catalyst’s market cap?

Health Catalyst’s market cap is €147.27M.

When is Health Catalyst’s upcoming earnings report date?

Health Catalyst’s upcoming earnings report date is Aug 12, 2026 which is in 24 days.

How were Health Catalyst’s earnings last quarter?

Health Catalyst released its earnings results on May 11, 2026. The company reported €0.017 earnings per share for the quarter, beating the consensus estimate of €0.01 by €0.008.

Is Health Catalyst overvalued?

According to Wall Street analysts Health Catalyst’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Health Catalyst pay dividends?

Health Catalyst does not currently pay dividends.

What is Health Catalyst’s EPS estimate?

Health Catalyst’s EPS estimate is 0.02.

How many shares outstanding does Health Catalyst have?

Health Catalyst has 73,894,020 shares outstanding.

What happened to Health Catalyst’s price movement after its last earnings report?

Health Catalyst reported an EPS of €0.017 in its last earnings report, beating expectations of €0.01. Following the earnings report the stock price went down -6.25%.

Which hedge fund is a major shareholder of Health Catalyst?

Currently, no hedge funds are holding shares in DE:2YP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Health Catalyst Stock Smart Score

Neutral

Fundamentals

Return on Equity

-99.78%

Trailing 12-Months

Asset Growth

-53.77%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Health Catalyst

Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.

Health Catalyst (2YP) Earnings & Revenues

Historic Earnings Reports

2YP Stock 12 Month Forecast

Average Price Target

€1.82

▲(68.62% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","1":"€1","2":"€2","3":"€3","4":"€4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.62231344,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€2.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.821051,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€1.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.52968284,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.53</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.74,1.8078702646153846,1.8757405292307692,1.9436107938461538,2.0114810584615386,2.079351323076923,2.1472215876923078,2.215091852307692,2.282962116923077,2.3508323815384617,2.418702646153846,2.486572910769231,2.5544431753846153,{"y":2.62231344,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.74,1.7462346923076923,1.7524693846153847,1.7587040769230768,1.7649387692307692,1.7711734615384616,1.777408153846154,1.783642846153846,1.7898775384615384,1.7961122307692308,1.8023469230769231,1.8085816153846153,1.8148163076923076,{"y":1.821051,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.74,1.723821756923077,1.7076435138461539,1.6914652707692308,1.6752870276923078,1.6591087846153847,1.6429305415384614,1.6267522984615383,1.6105740553846153,1.5943958123076922,1.5782175692307692,1.562039326153846,1.545861083076923,{"y":1.52968284,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.08,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.06,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.86,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.82,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.52,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.14,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.77,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.35,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.21,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >